Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥2,019 JPY
Change Today -16.00 / -0.79%
Volume 660.5K
4508 On Other Exchanges
Symbol
Exchange
Berlin
Tokyo
OTC US
OTC US
OTC US
As of 2:00 AM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for mitsubishi tanabe pharma (4508)

Mitsubishi Tanabe Pharma Corporation uses little or no debt in its capital structure and may have less financial risk than the industry aggregate. Cash Collection is a strong suit as the company is more effective than most in the industry. As of the end of 2014, its uncollected receivables totaled ¥123.5B JPY, which, at the current sales rate provides a Days Receivables Outstanding of 112.03. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 200.95 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2011
JPY
Mar 31
2012
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
4 Year
Trend
Assets    
Cash and Equivalents27,409.015,466.020,281.027,187.0
Short-Term Investments141,144.0177,136.0215,547.0278,619.0
TOTAL CASH AND SHORT TERM INVESTMENTS168,553.0192,602.0235,828.0305,806.0
Accounts Receivable128,330.0127,166.0129,825.0123,498.0
TOTAL RECEIVABLES128,330.0127,166.0129,825.0123,498.0
Inventory77,702.086,190.092,783.093,700.0
Deferred Tax Assets, Current12,551.09,343.08,373.08,153.0
Other Current Assets4,445.04,350.09,877.09,335.0
TOTAL CURRENT ASSETS391,581.0419,651.0476,686.0540,492.0
NET PROPERTY PLANT AND EQUIPMENT113,512.0103,929.092,283.098,340.0
Goodwill115,682.0105,549.099,527.096,180.0
Long-Term Investments180,574.0179,092.0189,473.0113,875.0
Deferred Tax Assets, Long Term13,789.07,898.04,173.0677.0
Other Intangibles3,567.03,806.04,632.036,912.0
TOTAL ASSETS818,705.0819,925.0866,774.0886,476.0
    
LIABILITIES & EQUITY    
Accounts Payable29,617.028,878.038,072.033,986.0
Accrued Expenses11,467.011,121.010,291.010,169.0
Short-Term Borrowings2,891.02,170.01,174.01,225.0
Current Portion of Long-Term Debt/Capital Lease------128.0
Current Income Taxes Payable37,921.024,479.033,665.026,934.0
Other Current Liabilities, Total5,826.02,936.02,916.09,395.0
TOTAL CURRENT LIABILITIES87,722.069,584.086,118.081,837.0
Long-Term Debt------958.0
Minority Interest5,758.05,740.04,993.011,791.0
Pension & Other Post-Retirement Benefits11,858.010,590.09,451.02,146.0
Deferred Tax Liability Non-Current11,450.09,338.08,365.013,356.0
Other Non-Current Liabilities11,716.08,928.09,918.010,342.0
TOTAL LIABILITIES122,746.098,440.0113,852.0108,639.0
Common Stock50,000.050,000.050,000.050,000.0
Additional Paid in Capital451,186.0451,186.0451,186.0451,186.0
Retained Earnings201,424.0224,168.0243,621.0266,575.0
Treasury Stock-407.0-486.0-487.0-490.0
Comprehensive Income and Other-12,002.0-9,123.03,609.0-1,225.0
TOTAL COMMON EQUITY690,201.0715,745.0747,929.0766,046.0
TOTAL EQUITY695,959.0721,485.0752,922.0777,837.0
TOTAL LIABILITIES AND EQUITY818,705.0819,925.0866,774.0886,476.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4508:JP ¥2,019.00 JPY -16.00

4508 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4508.
View Industry Companies
 

Industry Analysis

4508

Industry Average

Valuation 4508 Industry Range
Price/Earnings 22.6x
Price/Sales 2.8x
Price/Book 1.4x
Price/Cash Flow 18.1x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MITSUBISHI TANABE PHARMA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.